Conclusions: This study is the first to use experimental survey to assess PAMA. The result indicates that healthcare priorities form a base of trust between health care providers and patients. It further indicates that PAMA might increase if the healthcare provider refers to national expertise and patient organisations beliefs of a given treatment. This finding is supported by psychological theories of meaning-making 3 . Informing the patient about the views of the patient organisations and national expertise in the reasoning for a given treatment, may improve patient adherence to medical advices. Background: Well-coordinated multidisciplinary non-pharmacological care is considered to be a cornerstone in the management of patients with systemic sclerosis (SSc). However, unmet information and healthcare needs are found to be common in patients with SSc [1] . In addition, referrals by rheumatologists' do not always correspond with potential treatment goals as identified by health professionals (HP) [2] . Objectives: The aim of this study was to gain insight in the perspective of rheumatologists about the referral process of SSc patients to non-pharmacological care and to identify starting points for its optimisation. Methods: Semi structured in-depth interviews were held with 13 out of 24 rheumatologists, specialised in SSc management, from different Dutch university and regional medical centres. The qualitative data analysis used an inductive thematic analysis by moving through a process of coding in layers of abstraction and interpretation: familiarization with data, generating initial codes, grouping similar codes in categories, discussing categories, searching for themes among categories, reviewing themes, defining and naming themes, and producing the final report. Results: One major theme was identified as influencing decision making: "beliefs" and its three sub themes: a) beliefs about one's own professional role; b) beliefs about the patients' ability to take an active role in managing the disease and c) beliefs about the added value of non-pharmacological care. We also found an additional theme reflecting the "needs" of the rheumatologists regarding professional multidisciplinary collaboration (Figure 1 ). Another remarkable finding to be further explored was the discrepancy we found between the reliance of rheumatologists on established routines with regard to when and to whom to refer and the low confidence in HPs competencies on the other hand.
Conclusions:
The results of our study give insight that rheumatologists base their referral decisions on complex reasoning mindlines and beliefs about their own professional role, the patient's role and HP competencies.
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[1] Willems, L. M., Kwakkenbos, L., Leite, C. C., Thombs, B. D., van den Hoogen, F. J., Maia, A. C., & van den Ende, C. M. (2014 Background: Effective drug treatment for patients with inflammatory arthritis have brought a major proportion of patients in clinical remission. The need for regular follow-up intervals in specialized care is less; patients take greater responsibility for their own care, and patients request access to more flexible health care services. As a result of this development, the University Hospital, St.Olavs Hospital, Department of Rheumatology, has developed a on-demand pathway (PORS) for patients with inflammatory arthritis (RA, PsA and AS) in clinical remission or low disease-activity aiming for increased patient responsibility and flexibility. Objectives: The aim of this study was to investigate patients' satisfaction with PORS regarding disease status, treatment, knowledge, responsibility, and cooperation with health care professionals. Methods: We conducted a quest-back survey for patients included in PORS for ≥1 year in the period from June 2016 to October 2016. The survey contained 10 questions about the pathway. The response alternatives and scoring were: not at all =1, to a small extent =2, to some extent =3, to a large extent =4, to a very large extent =5, and not relevant =0. Results: We identified 1048 eligible patients, 10 invitations were returned (unknown address), and 312 responded (30%). The descriptive analyses (see table) showed that the patients in general considered their disease activity to be in a stable phase. The cooperation with their general practitioner was good, they had to some or large extent sufficient knowledge to take responsibility for the blood test controls and adhere to prescribed medication. The patients were to some extent satisfied with the renewals of prescriptions and access to health professionals. The patients were less satisfied with the "promise" of getting outpatient appointments within 14 days if needed. Finally, the patients would largely recommend PORS to other patients.
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Conclusions:
We found that patients with inflammatory arthritis in general were satisfied with a management pathway encouraging greater responsibility for managing their own care and the possibility for more flexible contacts with the health care services. However, fullfilling the promise of outpatient appointments within 14 days were not always possible to achieve. Background: Patients with musculoskeletal (MSK) disorders may remain on lengthy hospital outpatient waiting lists to be reviewed by a consultant doctor, although medical or surgical intervention may not be required (1,2). In 2012, a waiting list initiative saw the introduction of Advanced Practice Physiotherapists (APPs) across 16 hospitals in Ireland. APPs triage and manage patients awaiting a consultant doctor appointment, who are deemed non-urgent or unlikely to require surgery on screening of referral letters. APP scope of practice generally involves some traditionally medical-controlled acts such as: administering injections, ordering investigations/imaging, surgical listing and onward referral to hospital specialities; and depending on consultant doctor availability, their input may be sought on clinical decisions if required.
Objectives:
• Profile the national APP patient caseload • Establish the clinical outcomes of APP consultations Methods: A national database was established with all APPs (n=22) submitting patient data for 2014. These data were analysed using descriptive statistics. Background: DMARDs are beneficial for a number of rheumatic conditions. However, treatment effect may take a few weeks. On the other hand, patients may experience adverse effects (AEs) early on and they may not be able to follow complicated dosage titration regimen. In order to enhance treatment safety and empower self-management, rheumatic disease patients requiring initiation or change of DMARDs were recruited to a rheumatology nurse phone follow-up program. Objectives: (1) To evaluate the service outcomes of Rheumatology Nurse Phone follow-up Program and (2) explore the factors that may influence treatment adherence Methods: Upon initiation of DMARDs therapy at out-patient clinic or before hospital discharge, patients and/or their caregivers will be counseled for the new treatment plan and self-management knowledge by rheumatology nurse. A telephone follow-up by rheumatology nurse will be arranged within 4 weeks to monitor patients' condition. Treatment responses, AEs, drug concordance of patients and advice given in each phone consultation (PC) were recorded. Retrospective case review was performed. Results: There were 1230 episodes of PC performed by rheumatology nurse in 2015. 180 episodes of PC involved 76 patients (56 female) were randomly selected. The average number of PC was 2.4 times per case. The mean age of patient was 58 (24-85) years. Disease categories mainly involved rheumatoid arthritis (60.5%), systemic lupus erythematosus (7.9%), spondyloarthritis (5.3%) and gout (3.9%). The most common DMARDs prescribed were methotrexate (40.8%), hydroxychloroquine (27.6%), sulphasalazine (22.4%) and 39.5% of the study cases have received steroid courses. Among the 76 patients, 8 (10.5%) have taken wrong dosage and another 4 (5.3%) patients have not started therapy due to worries about potential AEs. Altogether 40 patients (52.6%) reported AEs after starting DMARDs. The most common AEs were rash, itchiness, dizziness, alopecia and oral ulcers. For non-adherence behaviour, 8 patients (10.5%) have self-stopped their medication and another 7 patients (9.2%) have self-adjusted the medication respectively. Eventually 90% of the cases were able to continue therapy with or without adjustment of regimes. Only 7 cases (9.2%) required interruption of current treatment or switching to other DMARDs due to AEs within the study period.
